Longitudinal plasma and cerebrospinal fluid analyses in Down syndrome: Results from the DABNI cohort

This longitudinal study examines biomarkers in plasma and cerebrospinal fluid from Down syndrome participants enrolled in the DABNI cohort to identify biological changes over time. The research uses objective laboratory analyses to advance understanding of Down syndrome neuropathology and disease progression.